Loading candles…
Artemis Medicare Services Ltd, incorporated in 2004, is a healthcare company headquartered in Gurgaon, India. Founded by the promoters of the Apollo Tyres Group, it operates a 541-bedded multi-specialty tertiary care hospital offering advanced medical and surgical interventions across more than 40 specialties. The company primarily serves the Delhi-NCR region, with expansion into New Gurugram and Mauritius. It has established 14 centers of excellence and is noted as the first hospital in Gurugram to obtain accreditation from both the Joint Commission International (JCI), USA, and the National Accreditation Board for Hospitals & Healthcare Providers (NABH). Artemis operates within the healthcare and hospital industries. There is a noted discrepancy regarding its incorporation year, with some sources stating 2007.
This page is a live market overview for ARTEMIS MED SERVICE LTD (ARTEMISMED) on the NSE. As a listed security, ARTEMIS MED SERVICE LTD is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for ARTEMISMED before placing trades on tick2trade.
As of the latest feed, ARTEMISMED last traded at ₹316.3 on NSE, up ₹4.6 (1.48%) from the previous close of ₹311.7. Today's session range is ₹312 – ₹321.95, against a 52-week band of ₹203.35 – ₹324.9. Traded volume today stands at 2.86L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for ARTEMISMED in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether ARTEMISMED is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for ARTEMIS MED SERVICE LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in ARTEMISMED. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated ARTEMISMED option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 | 3 Aug 2026 |
| Other | To consider and approve the Notice of the Postal Ballot for seeking the approval of Members of the Company for raising of funds | 4 Jun 2026 |
| Dividend | To consider and approve Audited Financial Results and recommendation of dividend, If any. | 8 May 2026 |
| Unaudited Results - Q3-FY25 | To consider and approve (i) the Un-audited Financial Results (Standalone & Consolidated) for the quarter/ nine months period ended December 31, 2025; and (ii… | 2 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 11 Nov 2025 |
| Unaudited Results - Q1-FY25 | To consider and approve the Un-audited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2025. | 5 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and dividend | 12 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.